International Tables for Crystallography (2006). Vol. F. ch. 1.3, pp. 10-25
https://doi.org/10.1107/97809553602060000656 |
Chapter 1.3. Macromolecular crystallography and medicine
Contents
- 1.3. Macromolecular crystallography and medicine (pp. 10-25) | html | pdf | chapter contents |
- 1.3.1. Introduction (p. 10) | html | pdf |
- 1.3.2. Crystallography and medicine (pp. 10-11) | html | pdf |
- 1.3.3. Crystallography and genetic diseases (pp. 11-12) | html | pdf |
- 1.3.4. Crystallography and development of novel pharmaceuticals (pp. 12-24) | html | pdf |
- 1.3.4.1. Infectious diseases (pp. 13-15) | html | pdf |
- 1.3.4.2. Resistance (pp. 15-21) | html | pdf |
- 1.3.4.3. Non-communicable diseases (pp. 21-24) | html | pdf |
- 1.3.4.4. Drug metabolism and crystallography (p. 24) | html | pdf |
- 1.3.4.5. Drug manufacturing and crystallography (p. 24) | html | pdf |
- 1.3.5. Vaccines, immunology and crystallography (pp. 24-25) | html | pdf |
- 1.3.6. Outlook and dreams (p. 25) | html | pdf |
- References | html | pdf |
- Figures
- Tables
- Table 1.3.3.1. Crystal structures and genetic diseases (p. 11) | html | pdf |
- Table 1.3.4.1. Important human pathogenic viruses and their proteins (pp. 14-15) | html | pdf |
- Table 1.3.4.2. Protein structures of important human pathogenic bacteria (pp. 16-18) | html | pdf |
- Table 1.3.4.3. Protein structures of important human pathogenic protozoa, fungi and helminths (pp. 19-20) | html | pdf |
- Table 1.3.4.4. Mechanisms of resistance (p. 20) | html | pdf |
- Table 1.3.4.5. Important human protein structures in drug design (pp. 22-23) | html | pdf |